Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
MESA LABORATORIES INC (MLAB) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
08/25/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "Amended and Restated Articles of Incorporation of Mesa Laboratories, Inc."
08/03/2023 8-K Quarterly results
Docs: "Mesa Labs Announces First Quarter Results"
05/25/2023 8-K Quarterly results
Docs: "Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results"
05/08/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/13/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Mesa Laboratories, Inc. Reports Immaterial Financial Exposure to Silicon Valley Bank Closure Lakewood, Colorado,"
02/06/2023 8-K Quarterly results
01/04/2023 8-K/A Submission of Matters to a Vote of Security Holders  Interactive Data
11/21/2022 8-K Quarterly results
11/04/2022 8-K Quarterly results
11/04/2022 8-K/A Quarterly results
11/03/2022 8-K Quarterly results
08/26/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
08/04/2022 8-K Quarterly results
06/27/2022 8-K Quarterly results
05/31/2022 8-K Quarterly results
04/05/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Open Market Sale AgreementSM  dated April 5, 2022 by and among Mesa Laboratories, Inc. and Jefferies LLC",
"Legal opinion of Davis, Graham, & Stubbs LLP"
03/30/2022 8-K Asset disposition
Docs: "Consent of the Independent Registered Accounting Firm",
"The unaudited condensed financial statements of Agena, which comprise (a) the unaudited condensed consolidated balance sheets as of September 30, 2021 and December 31, 2020; (b) the related unaudited condensed consolidated statements of income, comprehensive income, mezzanine equity and stockholders’ equity, and cash flows for the nine months ended September 30, 2021 and 2020, respectively; and (c) the related notes to the financial statements",
"The unaudited pro forma condensed combined statement of operations of Mesa Laboratories, Inc. for the nine months ended December 31, 2021 and the related notes to the unaudited pro forma condensed combined statement of operations",
"Updated portion of the Mesa Laboratories, Inc. Annual Report on Form 10-K for the fiscal year ended March 31, 2021"
02/03/2022 8-K Quarterly results
12/23/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Mesa Laboratories, Inc. Announces New Segment Reporting "
12/22/2021 8-K/A Financial Statements and Exhibits  Interactive Data
Docs: "Consent of Moss Adams, independent auditors for Agena Bioscience, Inc",
"Audited financial statements of Agena Bioscience, Inc., which comprise (a) the consolidated balance sheets as of December 31, 2020 and December 31, 2019; (b) the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for the years then ended, and (c) the related notes to the consolidated financial statements",
"Unaudited financial statements of Agena Bioscience, Inc, which comprise (a) the unaudited consolidated balance sheets as of June 30, 2021; (b) the related unaudited consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows; and (c) the related notes to the consolidated financial statements. ",
"(1) Unaudited pro forma condensed combined balance sheets of Mesa as of September 30, 2021; (2) unaudited pro forma condensed combined statement of operations of Mesa for the year ended March 31, 2021; (3) unaudited pro forma condensed combined statement of income of Mesa for the six months ended September 30, 2021; and (4) related notes to unaudited pro forma condensed combined financial statements"
11/04/2021 8-K Quarterly results
Docs: "Mesa Labs Announces Second Quarter Results"
10/29/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: ".6 OWENS PSU AWARD AGREEMENTS",
"Leader in Corporate Development and Strategy Joins Mesa Labs Board of Directors"
10/21/2021 8-K Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-B...
Docs: "Mesa Labs Closes Acquisition of Agena Bioscience"
09/29/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: ".1 GARY OWENS EMPLOYMENT AGMT",
".2 JOHN SAKYS EMPLOYMENT AGREEMENT",
".3 - GREG DINOIA EMPLOYMENT AGREEMENT",
".4 ARCHBOLD EMPLOYMENT AGREEMENT"
09/14/2021 8-K Quarterly results
09/03/2021 8-K Quarterly results
08/27/2021 8-K Quarterly results
08/05/2021 8-K Quarterly results
06/01/2021 8-K Quarterly results
03/08/2021 8-K Quarterly results
02/03/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "Mesa Labs Reports Second Quarter Results for FY21"
10/01/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy